The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
26 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $17,891,934 in first-year total cost, median $502,109.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]7
- Special Emphasis Panel[ZRG1 ETTN-P (13)]4
- Special Emphasis Panel[ZRG1 RPHB-D (16)]4
- Special Emphasis Panel[ZRG1 RPHB-Y (13)]4
- Special Emphasis Panel[ZRG1 ETTN-C (10)]3
Most frequent institutions
- OUI THERAPEUTICS, INC3
- Q-STATE BIOSCIENCES, INC.2
- ADAPTIVE TESTING TECHNOLOGIES1
- ALTO NEUROSCIENCE, INC.1
- BLUE OAK PHARMACEUTICALS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | HYBRID TYPE 1 EFFECTIVENESS-IMPLEMENTATION TRIAL FOR PRIMARY CARE DEPRESSION SCREENING AND REFERRAL TO A REMOTE DIGITAL MENTAL HEALTH CLINIC1R44MH126836-01A1 | PEIPER, NICHOLAS | MERU HEALTH MEDICAL, P.A., CA | $749,689 | ZRG1 |
| 2022 | Developing a virtual reality clinic to enhance telemental health.1R43MH129065-01 | BUNNELL, BRIAN E.ONG, TRITON | DOXY.ME, LLC, SC | $442,246 | ZRG1 |
| 2021 | Development and evaluation of novel high-density intracortical microelectrode arrays for clinical applications1R44MH125700-01A1 | ANGLE, MATTHEW RCASH, SYDNEY SQIAO, SHAOYU | PARADROMICS, INC., CA | $1,488,420 | ZRG1 |
| 2021 | Next generation drugs for bipolar depression and maintenance2R44MH116746-03 | LARGE, THOMAS H | BLUE OAK PHARMACEUTICALS, INC., MA | $1,425,888 | ZRG1 |
| 2021 | An Efficacy Trial of a Digital Therapeutic for Suicide Prevention2R42MH123357-02 | FEUERSTEIN, SETHSIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $1,249,571 | ZRG1 |
| 2021 | Finalizing and Testing an Online Therapist Training and Assistance Program to Facilitate Implementation of Comprehensive Behavioral Intervention for Tic Disorders (CBIT-Trainer)2R44MH111450-03A1 | HIMLE, MICHAEL BMOUTON-ODUM, SUZANNEWOODS, DOUGLAS W | PSYC TECH, LTD, TX | $1,202,047 | ZRG1 |
| 2021 | iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide1R44MH126819-01 | DIMEFF, LINDA ASCHAEFFER, CINDY M. | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $957,530 | ZRG1 |
| 2021 | Virtual neuro-navigation system for personalized,community-based TMS1R44MH126833-01A1 | TRUONG, DENNIS QUANGVINH | SOTERIX MEDICAL,INC., NJ | $449,991 | ZRG1 |
| 2021 | Limbix Spark: a CBT-based mobile intervention for adolescent depression1R44MH125636-01 | COMPTON, SCOTT NLAKE, JESSICAPERAKSLIS, ERIC D | LIMBIX HEALTH, INC., CA | $449,928 | ZRG1 |
| 2021 | Mobile Technology for Reducing and Preventing Adolescent Suicide1R43MH125691-01 | FEUERSTEIN, SETHSIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $398,984 | ZRG1 |
| 2021 | Non-genetic optical stimulation platform for the next-generation neuroscience drug discovery assays1R43MH124563-01A1 | SAVTCHENKO, ALEX | NANOTOOLS BIOSCIENCE, CA | $350,122 | ZRG1 |
| 2021 | Placement Success Predictor: Using Site-Customized Machine Learning Models to Predict the Best Level of Care Placement for Each Child's Behavioral Health Needs1R43MH125486-01 | TRUDEAU, KIMBERLEE JEAN | OUTCOME REFERRALS INC, MA | $220,720 | ZRG1 |
| 2020 | Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression1R44MH123373-01 | ETKIN, AMIT | ALTO NEUROSCIENCE, INC., CA | $988,093 | ZRG1 |
| 2020 | A Mightier healthcare system: Introducing a game-based pediatric mental health intervention into payor-sponsored care to evaluate financial and clinical outcomes1R44MH124574-01 | KAHN, JASON | NEUROMOTION, INC., MA | $736,923 | ZRG1 |
| 2020 | Message-based psychotherapy and digital treatment sequences for depression1R44MH124334-01 | HULL, THOMAS DERRICK | TALKSPACE LLC, NY | $705,275 | ZRG1 |
| 2020 | Goalspace: A Platform for Parent-Assisted Behavioral Interventions1R44MH124562-01 | JAKOBOVITS, REX M | EXPERIAD, LLC, HI | $549,319 | ZRG1 |
| 2020 | A Digital Therapeutic to Advance the Delivery of Effective Interventions for Suicide Prevention1R43MH123357-01 | FEUERSTEIN, SETH | OUI THERAPEUTICS, INC, CT | $481,035 | ZRG1 |
| 2020 | Applied Social Cognitive Skills in the Workplace for Transition-Aged Youth with Autism Spectrum Disorder1R44MH123359-01 | OLSEN, DALE EDWARD | SIMMERSION, LLC., MD | $449,755 | ZRG1 |
| 2020 | Care Improving Cognition for ADolescents on the Autism Spectrum (CICADAS)1R43MH124542-01A1 | BIAGIANTI, BRUNO | POSIT SCIENCE CORPORATION, CA | $360,194 | ZRG1 |
| 2019 | Optopatch:high-throughput all-optical electrophysiology2R44MH112474-05A1 | DEMPSEY, GRAHAM THOMASWERLEY, CHRISTOPHER | Q-STATE BIOSCIENCES, INC., MA | $1,364,122 | ZRG1 |
| 2019 | Scalable, all-optical assays of synaptic function and plasticity2R44MH112273-03 | DEMPSEY, GRAHAM THOMASWERLEY, CHRISTOPHER | Q-STATE BIOSCIENCES, INC., MA | $777,880 | ZRG1 |
| 2019 | Teaching attentional awareness and control in ADHD1R44MH122109-01 | SIMPSON, GREGORY V | THINK NOW, INC., CA | $523,183 | ZRG1 |
| 2019 | Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders1R43MH121136-01 | LEISER, STEVEN | PSYCHOGENICS, INC., NJ | $449,973 | ZRG1 |
| 2019 | Multi-channel functional imaging tool for neuropsychological drug development1R43MH121179-01 | ZHAO, YOUBO | PHYSICAL SCIENCES, INC, MA | $446,130 | ZRG1 |
| 2019 | Computerized Adaptive Suicidal Risk Stratification and Prediction1R44MH118780-01A1 | BOUDREAUX, EDWIN DCOHEN, YEHUDA | ADAPTIVE TESTING TECHNOLOGIES, IL | $224,998 | ZRG1 |
| 2018 | Neuroinformatics platform using machine learning and content-based image retrieval for neuroscience image data1R44MH118815-01 | ANGSTMAN, PAUL | MICROBRIGHTFIELD, LLC, VT | $449,918 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.